Our clinical network treats 700,000+ patients a month · Free shipping

← All articles

Guides

How to Keep the Weight Off After a GLP-1: The Maintenance Playbook (2026)

September 3, 20268 min read

The hard part of a GLP-1 isn't losing the weight — it's the window after, when the medication is gone and appetite comes back. Almost no program supports that window, which is why so much regain happens by default. It doesn't have to. Here's the playbook, built from where the evidence actually points. For the full off-ramp picture, start at our staying-off guide.

Protein: the appetite lever that still works

When the medication leaves your system, protein does the most to blunt the hunger it was quieting — it's the most satiating macronutrient per calorie. A common target is roughly 0.7–1 gram of protein per pound of goal body weight per day, spread across meals, with protein first on the plate. This is the single habit most associated with holding a result.

Resistance training: protect the muscle, protect the metabolism

A meaningful share of rapid weight loss can be lean mass, and losing muscle drags resting metabolism down with it. Two full-body resistance sessions a week — covering push, pull, hinge, and squat, with the load progressing over time — signal your body to keep the muscle. We cover this in depth in tirzepatide and muscle loss.

Sleep and stress: the pillar people skip

Short sleep and chronic stress raise the hormones that drive appetite and fat storage, and they quietly undo the other habits. A consistent 7–9 hours, with a regular sleep and wake time, does more than any single perfect night.

Monitor the trend, catch regain early

  • Weigh in once a week, same day and conditions — watch the trend over a month, not any single morning.
  • Notice the return of food noise; it often comes back before the scale moves and is your earliest signal.
  • Track how you feel — energy, strength, how clothes fit — which tells you whether you're holding lean mass.

When restarting is the right call

For many people obesity is a chronic condition, and restarting is no more a failure than resuming blood-pressure medication would be. If the trend turns and won't turn back despite your effort, that's a medical signal — talk to a provider early. Our staying-off guide covers the decision, and because StaveMD is one flat price at every dose, restarting doesn't mean climbing a price ladder again.

Want a structured hand through the maintenance window? Landed, our iPhone app for life after GLP-1s, builds a 12-week protocol with protein floors and a Rebound Radar that catches regain early.

Take the eligibility check

No labs required. Anonymous. Free.

This article is for informational purposes only and does not constitute medical advice. Compounded tirzepatide is not FDA-approved. A licensed provider determines whether treatment is appropriate for you. Read how we source and review content and the references behind the clinical figures used on this site.